LOS ANGELES, CA / ACCESSWIRE / September 8, 2016 / Ezequiel Lukinskas, CEO of Biogenica, is pleased to announce the launch of the Panacea Project: Cancer Treatment Research. To learn more about this ...
Recent updates from the research team confirm that Project Panacea continues to demonstrate strong preclinical performance, including selective targeting of breast cancer cells while minimizing harm ...
TheraSyn Bio and Rubix LS have announced a groundbreaking joint venture, Project Panacea, to develop a topical breast cancer therapy. Combining synthetic biology and AI-driven patient insights, the ...
Project Panacea, a topical breast cancer therapy, moves closer to clinical trials with strong preclinical progress. BOSTON, MA, UNITED STATES, June 11, 2025 /EINPresswire / -- TheraSyn Bio , a ...